MAPK8 and neurodegenerative disease: Accordingly, control of MAPK signaling pathways has long been discussed as a potential therapeutic target in neurodegenerative diseases, including AMD [8,33,34]; however, there have been no data on JNK signaling in the retina and its changes with aging and with AMD development.